National Centre for the Development of Gene Therapy and RNA Technology Medicines

The Foundation carries out research in areas of strategic importance for the production of therapies or for the design of procedures for human health, integrating the development of therapies with their targeted delivery. Its aim is to create and renew research infrastructures and laboratories, to implement and develop research programmes and activities in order to encourage the establishment and growth of entrepreneurial initiatives with a higher technological content, and to enhance the value of research results in the specified fields.
The Foundation, of which the University of Padua is the proposing institution and lead partner, involves 49 entities including universities, public research bodies, private organisations and companies.
Theme: Development of gene therapy and drugs using RNA technology
Unipd project contact: Rosario Rizzuto
Proposing institution: University of Padua
Implementing body: National Centre for the Development of Gene Therapy and Drugs using RNA Technology
Website: https://www.rna-genetherapy.eu/
- University of Padua
- National Research Council
- Humanitas University
- Italian Institute of Technology
- Bambino Gesù Paediatric Hospital
- Ri.MED Foundation
- Magna Grecia University
- University of Bari
- University of Bologna
- University of Brescia
- University of Cagliari
- University of Campania – Vanvitelli
- G. D'Annunzio University
- University of Catania
- University of Firenze
- University of Milano
- University of Milano-Bicocca
- University of Modena e Reggio Emilia
- University of Napoli Federico II
- University of Palermo
- University of Pisa
- University of Pavia
- Sapienza University of Roma
- University of Roma Tor Vergata
- University of Salerno
- University of Siena
- Vita-Salute San Raffaele University
- University of Torino
- University of Trieste
- University of Verona
- Tettamanti Foundation
- Telethon Foundation
- Dompè Farmaceutici SpA
- Takis Biotech Srl
- Chiesi Farmaceutici SpA
- Eurofins Biolab Srl
- Novartis International AG
- Pfizer INC
- Stevanato Group SpA
- PBL Srl
- Innovavector Srl
- Sanofi
- Astrazeneca
- Bracco SpA
- BioNTech
- Antares Vision Group Spa
- Orgenesis Italy Srl
- IRBM SpA
- Intesa Sanpaolo Spa
